Table 1.
Basal characteristics of the total study population and divided into genders
| Variables | Total population | Males | Females | p-value |
|---|---|---|---|---|
| N | 476 | 242 | 234 | |
| Age, mean (SD) | 77.0 (3.4) | 77.0 (3.2) | 77.0 (3.7) | |
| BMI, (SD) | 27.2 (4.3) | 26.7 (3.3) | 27.6 (5.1) | 0.02 |
| IHD, n (%) | 105 (22.1) | 63 (26.0) | 42 (17.9) | 0.03 |
| Hypertension, n (%) | 359 (75.4) | 174 (71.9) | 185 (79.1) | 0.003 |
| ACEI/ARB, n (%) | 125 (26.3) | 64 (26.4) | 61 (26.1) | 0.93 |
| Hb < 120 g/L, n (%) | 51 (10.7) | 16 (6.6) | 35 (15.0) | 0.003 |
| Beta blockers, n (%) | 168 (35.3) | 90 (37.2) | 78 (33.3) | 0.38 |
| b-glucose, mmol/L, mean, (SD) | 4.6 (1.3) | 4.5 (1.2) | 4.6 (1.4) | 0.57 |
| HDL, mmol/L mean, (SD) | 1.5 (0.4) | 1.3 (0.3) | 1.6 (0.4) | <0.0001 |
| eGFR < 60 mL/min, n (%) | 233 (48.9) | 116 (47.9) | 117 (50.0) | 0.65 |
| CRP, mg/L, mean (SD) | 11.0 (5.1) | 11.0 (5.0) | 11.0 (5.3) | 0.68 |
| EF < 40 %, n (%) | 36 (7.6) | 27 (11.2) | 9 (3.8) | 0.003 |
| NT-proBNP ng/L, mean, (SD) | 188 (319) | 201 (395) | 174 (200) | 0.37 |
| Adiponectin pg/mL, mean, (SD) | 6263 (4690) | 4829 (3391) | 7884 (5387) | <0.0001 |
Notes: ACEI/ARB: Angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; BMI: Body mass index; CRP: C-reactive protein; EF: Ejection fraction; eGRF: Estimated glomerular filtration rate; HDL; High density lipoproteins; IHD: Ischemic heart disease; NT-proBNP: N-terminal fragment of proBNP